What is Altus Research?
Altus Clinical Research operates as a specialized, privately held research facility dedicated to the execution of Phase I through Phase IV clinical trials. The company maintains a robust footprint in the medical research sector, with specific expertise in dermatology, urology, and women's health. By bridging the gap between pharmaceutical sponsors and patient populations, Altus facilitates the development of novel therapeutic interventions for chronic conditions such as psoriasis and overactive bladder. Their business model is predicated on high-fidelity data collection, rigorous adherence to ethical standards, and a collaborative approach that integrates community physicians into the broader clinical research framework, thereby enhancing the quality and reliability of healthcare outcomes.
How much funding has Altus Research raised?
Altus Research has raised a total of $365K across 2 funding rounds:
Debt
$150K
Debt
$215K
Debt (2020): $150K with participation from PPP
Debt (2021): $215K led by PPP
Key Investors in Altus Research
PPP
Public-Private Partnership
What's next for Altus Research?
With the recent influx of capital, Altus Research is well-positioned to expand its therapeutic focus and increase its throughput of clinical trials. The company's strategic roadmap likely involves upgrading its diagnostic infrastructure and deepening its partnerships with global pharmaceutical entities to accelerate the drug development lifecycle. As the firm transitions through this late-stage growth phase, the focus will remain on maintaining the high safety and compliance standards that have become the hallmark of its operations. Future initiatives may include the adoption of advanced digital health technologies to streamline participant recruitment and data management, further cementing its role as a premier site for medical innovation in the United States.
See full Altus Research company page
